{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:11:12Z","timestamp":1784956272245,"version":"3.55.0"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2018.00451","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T07:24:08Z","timestamp":1537946648000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence"],"prefix":"10.3389","volume":"9","author":[{"given":"Yanjun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4038\/cmj.v60i4.8218","article-title":"Friendly fire on neurons: antibody-mediated diseases of the nervous system","volume":"60","author":"Chang","year":"2015","journal-title":"Ceylon Med J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1474-4422(12)70301-0","article-title":"The expanding range of autoimmune disorders of the nervous system","volume":"12","author":"Wildemann","year":"2013","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5694\/mjao12.10628","article-title":"Depression and anxiety","volume":"1","author":"Tiller","year":"2012","journal-title":"Med J Aust."},{"key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1556\/OH.2014.29968","article-title":"Post-stroke depression","volume":"155","author":"Schulte-Altedorneburg","year":"2014","journal-title":"Orv Hetil."},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/1567205012666150204124310","article-title":"The prevalence of depression in Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Chi","year":"2015","journal-title":"Curr Alzheimer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1017\/S0924270800035705","article-title":"Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression","volume":"12","author":"Nowak","year":"2000","journal-title":"Acta Neuropsychiatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0303-8467(02)00036-7","article-title":"The worldwide prevalence of multiple sclerosis","volume":"104","author":"Pugliatti","year":"2002","journal-title":"Clin Neurol Neurosurg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrneurol.2014.139","article-title":"The link between multiple sclerosis and depression","volume":"10","author":"Feinstein","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J Neurol Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-2006-924938","article-title":"Mental disorders associated with multiple sclerosis","volume":"131","author":"Wilkening","year":"2006","journal-title":"Dtsch Med Wochenschr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"Doc02","DOI":"10.3205\/000170","article-title":"The risk of developing depression when suffering from neurological diseases","volume":"11","author":"Thielscher","year":"2013","journal-title":"Ger Med Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1176\/jnp.23.2.jnp198","article-title":"Relationships between multiple sclerosis and depression","volume":"23","author":"Byatt","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s004150170184","article-title":"Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects","volume":"248","author":"Zorzon","year":"2001","journal-title":"J Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00406-013-0448-6","article-title":"Depressive syndromes in neurological disorders","volume":"263","author":"Hellmann-Regen","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1177\/0883073812450750","article-title":"Fatigue and depression in children with demyelinating disorders","volume":"28","author":"Parrish","year":"2013","journal-title":"J Child Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpsychores.2017.10.006","article-title":"Does the presence of multiple sclerosis impact on symptom profile in depressed patients?","volume":"103","author":"Boeschoten","year":"2017","journal-title":"J Psychosom Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1177\/0883073810368995","article-title":"Torticollis as the only manifestation of acute disseminated encephalomyelitis","volume":"25","author":"Har-Gil","year":"2010","journal-title":"J Child Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/PEC.0000000000000825","article-title":"Acute disseminated encephalomyelitis","volume":"32","author":"Gray","year":"2016","journal-title":"Pediatr Emerg Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2169\/internalmedicine.40.1149","article-title":"Severe depression as an initial symptom in an elderly patient with acute disseminated encephalomyelitis","volume":"40","author":"Matsuda","year":"2001","journal-title":"Int Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.clineuro.2005.11.024","article-title":"Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis","volume":"108","author":"Habek","year":"2006","journal-title":"Clin Neurol Neurosurg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4103\/0019-5545.91913","article-title":"Acute disseminated encephalomyelitis presenting as depressive episode","volume":"53","author":"Krishnakumar","year":"2011","journal-title":"Indian J Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1176\/appi.neuropsych.23.1.90","article-title":"The emerging link between autoimmune disorders and neuropsychiatric disease","volume":"23","author":"Kayser","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/15622970701829681","article-title":"Limbic encephalitis presenting with anxiety and depression: a comprehensive neuropsychological formulation","volume":"10","author":"Yalu\u00f0*","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1177\/0883073812460585","volume-title":"Acquired Demyelinating and Other Autoimmune Disorders of the Central Nervous System in Children","author":"Alper","year":"2012"},{"key":"B31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1468-1331.2010.03252.x","article-title":"Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica","volume":"18","author":"Chanson","year":"2011","journal-title":"Eur J Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2016.02.011","article-title":"Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression","volume":"293","author":"Shi","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/0019-5545.105509","article-title":"Psychiatric morbidity in patients with transverse myelitis and stroke: a comparison","volume":"55","author":"Baweja","year":"2013","journal-title":"Indian J Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"J Neurol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.05.007","article-title":"Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica","volume":"283","author":"Akaishi","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/cns.12411","article-title":"Hypoxemia, sleep disturbances, and depression correlated with fatigue in neuromyelitis optica spectrum disorder","volume":"21","author":"Pan","year":"2015","journal-title":"CNS Neurosci Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1212\/NXI.0000000000000286","article-title":"Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder","volume":"3","author":"Chavarro","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B38","first-page":"383","article-title":"Chapter 21\u2013he Guillain\u2013Barr\u00e9 syndrome","volume-title":"Elsevier Handbook of Clinical Neurology","author":"Fujimura","year":"2013"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jns5.12053","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go","volume":"19","author":"Eduardo","year":"2014","journal-title":"J Peripher Nerv Syst."},{"key":"B40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/nedt.1.2.145.61047","article-title":"Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barr\u00e9 syndrome: some preliminary observations","volume":"1","author":"Brousseau","year":"2005","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1007\/s00415-010-5653-x","article-title":"Factors associated with long-term functional outcomes and psychological sequelae in Guillain\u2013Barre syndrome","volume":"257","author":"Khan","year":"2010","journal-title":"J Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jocn.2017.06.041","article-title":"Neuropsychiatric debut as a presentation of Guillain-Barr\u00e9 Syndrome: an atypical clinical case and literature review","volume":"44","author":"Sangroula","year":"2017","journal-title":"J Clin Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jns.2017.08.022","article-title":"Risk of psychiatric disorders in Guillain-Barre syndrome: a nationwide, population-based, cohort study","volume":"381","author":"Tzeng","year":"2017","journal-title":"J Neurol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1529-8027.2009.00243.x","article-title":"Recurrences, vaccinations and long-term symptoms in GBS and CIDP","volume":"14","author":"Kuitwaard","year":"2009","journal-title":"J Peripher Nerv Syst."},{"key":"B46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000047956","article-title":"Psychotic symptoms and emotional distress in patients with guillain-barr\u00e9 syndrome","volume":"47","author":"Weiss","year":"2002","journal-title":"Eur Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1468-1331.2009.02906.x","article-title":"What constitutes a \u2018good' recovery outcome in post-acute Guillain-Barre syndrome?","volume":"17","author":"Davidson","year":"2010","journal-title":"Eur J Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000445347","article-title":"Fatigue, pain, anxiety and depression in guillain-barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"75","author":"Merkies","year":"2016","journal-title":"Eur Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1212\/01.WNL.0000148589.87107.9C","article-title":"Physical training and fatigue, fitness, and quality of life in Guillain\u2013Barr\u00e9 syndrome and CIDP","volume":"63","author":"Garssen","year":"2004","journal-title":"Neurology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e00538","DOI":"10.1002\/brb3.538","article-title":"Fatigue in myasthenia gravis: risk factors and impact on quality of life","volume":"6","author":"Sarah","year":"2016","journal-title":"Brain Behav."},{"key":"B52","first-page":"117","article-title":"Neuropsychological performance in patients with myasthenia gravis","volume":"77","author":"Eizaguirre","year":"2017","journal-title":"Medicina"},{"key":"B53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2165\/00023210-200721060-00004","article-title":"Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment","volume":"21","author":"Kulaksizoglu","year":"2007","journal-title":"CNS Drugs"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e000313","DOI":"10.1136\/bmjopen-2011-000313","article-title":"Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study","volume":"1","author":"Suzuki","year":"2011","journal-title":"BMJ Open"},{"key":"B55","first-page":"640","article-title":"Coping with illness in myasthenia gravis","volume":"64","author":"Doering","year":"1993","journal-title":"Nervenarzt"},{"key":"B56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fphar.2013.00158","article-title":"Mind and body: how the health of the body impacts on neuropsychiatry","volume":"4","author":"Renoir","year":"2013","journal-title":"Front Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/135245850100700611","article-title":"The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope","volume":"7","author":"Lynch","year":"2001","journal-title":"Mult Scler J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1191\/1352458503ms854oa","article-title":"The role of helplessness as mediator between neurological disability, emotional instability, experienced fatigue and depression in patients with multiple sclerosis","volume":"9","author":"van","year":"2003","journal-title":"Mult Scler J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1017\/S104161021200107X","article-title":"Anxiety, depression, and comorbid anxiety and depression: risk factors and outcome over two years","volume":"24","author":"Almeida","year":"2012","journal-title":"Int Psychogeriatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbi.2004.10.003","article-title":"Acute inflammation and negative mood: mediation by cytokine activation","volume":"19","author":"Wright","year":"2005","journal-title":"Brain Behav Immun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.iac.2009.02.008","article-title":"Depression and immunity: inflammation and depressive symptoms in multiple sclerosis","volume":"29","author":"Gold","year":"2009","journal-title":"Immunol Allergy Clin North Am."},{"key":"B62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pnpbp.2015.11.012","article-title":"Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances","volume":"66","author":"Haapakoski","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: where do we stand?","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav Immun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbi.2012.11.010","article-title":"Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression","volume":"28","author":"Gibney","year":"2013","journal-title":"Brain Behav Immun."},{"key":"B65","first-page":"127","article-title":"Multiple sclerosis\u2013presenting as depressive illness","volume":"38","author":"Goodstein","year":"1977","journal-title":"Dis Nerv Syst."},{"key":"B66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1468-1331.2002.00442.x","article-title":"Depressive symptoms and MRI changes in multiple sclerosis","volume":"9","author":"Zorzon","year":"2002","journal-title":"Eur J Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"148465","DOI":"10.1155\/2014\/148465","article-title":"Depressive symptoms in multiple sclerosis from an in vivo study with TBSS","volume":"2014","author":"Shen","year":"2014","journal-title":"Biomed Res Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Struct Funct."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1177\/1352458517692886","article-title":"Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis","volume":"23","author":"Pravata","year":"2017","journal-title":"Mult Scler."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518767051.","article-title":"Fronto-limbic disconnection in patients with multiple sclerosis and depression","author":"van","year":"2018","journal-title":"Mult Scler."},{"key":"B71","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1212\/WNL.59.5.744","article-title":"Interferon \u03b21a and depression in secondary progressive MS: data from the SPECTRIMS Trial","volume":"59","author":"Patten","year":"2002","journal-title":"Neurology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000077739","article-title":"Drug-induced depression: a systematic review to inform clinical practice","volume":"73","author":"Patten","year":"2004","journal-title":"Psychother Psychosom."},{"key":"B73","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.msard.2013.11.005","article-title":"Short-term and long-term safety and tolerability of interferon \u03b2-1b in multiple sclerosis","volume":"3","author":"Reder","year":"2014","journal-title":"Mult Scler Relat Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s00415-016-8146-8","article-title":"Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial","volume":"263","author":"Schippling","year":"2016","journal-title":"J Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/135245850000600509","article-title":"Multiple sclerosis, disease modifying treatments and depression: a critical methodological review","volume":"6","author":"Feinstein","year":"2000","journal-title":"Mult Scler J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.eurpsy.2005.09.013","article-title":"Psychiatric side effects of interferon-\u03b2 in multiple sclerosis","volume":"21","author":"Goeb","year":"2006","journal-title":"Eur Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/1352458511417835","article-title":"Multiple sclerosis and depression","volume":"17","author":"Feinstein","year":"2011","journal-title":"Mult Scler J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"370","DOI":"10.6061\/clinics\/2016(07)03","article-title":"Determinants of quality of life in Brazilian patients with myasthenia gravis","volume":"71","author":"Mour\u00e3o","year":"2016","journal-title":"Clinics"},{"key":"B79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0022-3999(00)00187-2","article-title":"Exogenous corticosteroids and major depression in the general population","volume":"49","author":"Patten","year":"2000","journal-title":"J Psychosom Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","article-title":"Quality of life and life circumstances in German myasthenia gravis patients","volume":"8","author":"Twork","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1170-2","article-title":"Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)","volume":"33","author":"Basta","year":"2012","journal-title":"Neurol Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3109\/00207454.2015.1038712","article-title":"Quality of life in 188 patients with myasthenia gravis in China","volume":"126","author":"Yang","year":"2016","journal-title":"Int J Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.msard.2018.03.009","article-title":"Prevalence of and risk factors for cognitive impairment in patients with relapsing-remitting multiple sclerosis: multi-center, controlled trial","volume":"22","author":"Ozakbas","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"B84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jns.2003.10.012","article-title":"Depressive symptoms account for deficient information processing speed but not for impaired working memory in early phase multiple sclerosis (MS)","volume":"217","author":"Landr\u00f8","year":"2004","journal-title":"J Neurol Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"519785","DOI":"10.1155\/2015\/519785","article-title":"Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis","volume":"2015","author":"Nunnari","year":"2015","journal-title":"Biomed Res Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1586\/ern.10.99","article-title":"Multiple sclerosis-associated fatigue","volume":"10","author":"Krupp","year":"2010","journal-title":"Expert Rev Neurother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2165\/00023210-200216070-00002","article-title":"Cognitive dysfunction in multiple sclerosis","volume":"16","author":"Bagert","year":"2002","journal-title":"CNS Drugs"},{"key":"B88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/qjmed\/hcm122","article-title":"A medical definition of fatigue in multiple sclerosis","volume":"101","author":"Mills","year":"2008","journal-title":"QJM Int J Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00018-009-0184-2","article-title":"Fatigue in neuromuscular disorders: focus on Guillain-Barre syndrome and Pompe disease","volume":"67","author":"de Vries","year":"2010","journal-title":"Cell Mol Life Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jns.2012.08.007","article-title":"Fatigue in multiple sclerosis\u2013a brief review","volume":"323","author":"Induruwa","year":"2012","journal-title":"J Neurol Sci."},{"key":"B91","first-page":"105","article-title":"Fatigue, depression, and physical impairment in multiple sclerosis","volume":"13","author":"Azimian","year":"2014","journal-title":"Iran J Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jns.2017.07.047","article-title":"Depression and fatigue in patients with multiple sclerosis","volume":"380","author":"Greeke","year":"2017","journal-title":"J Neurol Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2016.08.004","article-title":"Co-occurrence and symptomatology of fatigue and depression","volume":"71","author":"Corfield","year":"2016","journal-title":"Compr Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T21:58:44Z","timestamp":1571954324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2018.00451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":93,"alternative-id":["10.3389\/fpsyt.2018.00451"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2018.00451","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"article-number":"451"}}